SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-23-001760
Filing Date
2023-08-11
Accepted
2023-08-11 12:22:18
Documents
60
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q eyen-20230630x10q.htm   iXBRL 10-Q 1250720
2 EX-31.1 eyen-20230630xex31d1.htm EX-31.1 13466
3 EX-31.2 eyen-20230630xex31d2.htm EX-31.2 13521
4 EX-32.1 eyen-20230630xex32d1.htm EX-32.1 7017
5 EX-32.2 eyen-20230630xex32d2.htm EX-32.2 6811
  Complete submission text file 0001410578-23-001760.txt   5865490

Data Files

Seq Description Document Type Size
6 EX-101.SCH eyen-20230630.xsd EX-101.SCH 48369
7 EX-101.CAL eyen-20230630_cal.xml EX-101.CAL 45938
8 EX-101.DEF eyen-20230630_def.xml EX-101.DEF 128518
9 EX-101.LAB eyen-20230630_lab.xml EX-101.LAB 350256
10 EX-101.PRE eyen-20230630_pre.xml EX-101.PRE 276757
54 EXTRACTED XBRL INSTANCE DOCUMENT eyen-20230630x10q_htm.xml XML 1063793
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

IRS No.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38365 | Film No.: 231162515
SIC: 2834 Pharmaceutical Preparations